Prestige Consumer Healthcare Inc. (PBH) Financial Statements (2026 and earlier)

Company Profile

Business Address 660 WHITE PLAINS RD.
TARRYTOWN, NY 10591
State of Incorp.
Fiscal Year End March 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)
Annual | Quarterly

3/31/2026
Q4
12/31/2025
Q3
9/30/2025
Q2
6/30/2025
Q1
3/31/2025
Q4
12/31/2024
Q3
9/30/2024
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments62,373119,106139,50297,88450,87451,540
Cash and cash equivalent62,373119,106139,50297,88450,87451,540
Receivables190,456199,000168,405194,293167,274163,547
Inventory, net of allowances, customer advances and progress billings163,594158,996153,126147,709151,516156,225
Inventory163,594158,996153,126147,709151,516156,225
Other undisclosed current assets17,00520,30919,4858,4427,5009,396
Total current assets:433,428497,411480,518448,328377,164380,708
Noncurrent Assets
Finance lease, right-of-use asset, after accumulated amortization22,59623,41624,23625,0564,943212
Operating lease, right-of-use asset23,92825,42726,91828,23829,6588,551
Property, plant, and equipment, after accumulated depreciation, depletion, and amortization128,21473,10073,78674,54873,52474,920
Intangible asset, including goodwill, after accumulated amortization2,882,7842,819,4842,823,1432,822,7752,837,8692,845,767
Goodwill581,248528,411528,314527,425527,219529,225
Intangible asset, excluding goodwill, after accumulated amortization2,301,5362,291,0732,294,8292,295,3502,310,6502,316,542
Other noncurrent assets3,7933,4423,0243,2736,3396,727
Total noncurrent assets:3,061,3152,944,8692,951,1072,953,8902,952,3332,936,177
TOTAL ASSETS:3,494,7433,442,2803,431,6253,402,2183,329,4973,316,885
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities124,286119,65396,04191,67088,92099,851
Accounts payable42,94641,92422,20618,92519,50631,172
Accrued liabilities81,34077,72973,83572,74569,41468,679
Debt2,6142,5722,5302,49090091
Other undisclosed current liabilities12,65712,37911,09712,46312,7256,964
Total current liabilities:139,557134,604109,668106,623102,545106,906
Noncurrent Liabilities
Long-term debt and lease obligation18,65219,31919,97620,6241,004,0771,060,126
Long-term debt, excluding current maturities     1,000,0001,060,000
Finance lease, liability18,65219,31919,97620,6244,077126
Liabilities, other than long-term debt473,536470,242453,750450,587442,473426,506
Deferred income tax liabilities449,331444,924426,947419,594413,276414,865
Liability, pension and other postretirement and postemployment benefits   2,870  
Other liabilities5,7475,3795,4065,3915,0295,124
Operating lease, liability18,45819,93921,39722,73224,1686,517
Other undisclosed noncurrent liabilities1,033,547993,146992,749989,487(8,031)(8,414)
Total noncurrent liabilities:1,525,7351,482,7071,466,4751,460,6981,438,5191,478,218
Total liabilities:1,665,2921,617,3111,576,1431,567,3211,541,0641,585,124
Equity
Equity, attributable to parent1,829,4511,824,9691,855,4821,834,8971,788,4331,731,761
Common stock562562561560559557
Treasury stock, value(438,547)(392,228)(316,330)(277,208)(265,843)(263,498)
Additional paid in capital605,495602,756600,238593,402588,207576,596
Accumulated other comprehensive loss(30,234)(31,600)(32,255)(37,659)(40,164)(26,536)
Retained earnings1,692,1751,645,4791,603,2681,555,8021,505,6741,444,642
Total equity:1,829,4511,824,9691,855,4821,834,8971,788,4331,731,761
TOTAL LIABILITIES AND EQUITY:3,494,7433,442,2803,431,6253,402,2183,329,4973,316,885

Income Statement (P&L) ($ in thousands)
Annual | Quarterly

3/31/2026
Q4
12/31/2025
Q3
9/30/2025
Q2
6/30/2025
Q1
3/31/2025
Q4
12/31/2024
Q3
9/30/2024
Q2
Revenues283,444274,114249,530289,396290,317283,785
Cost of revenue(126,075)(122,535)(109,199)(127,564)(129,268)(126,403)
Gross profit:157,369151,579140,331161,832161,049157,382
Operating expenses(74,878)(71,909)(68,575)(85,333)(69,087)(73,043)
Operating income:82,49179,67071,75676,49991,96284,339
Nonoperating income (expense)
(Other Nonoperating Income (Expense))		(10,005)(501)224(5,281)(353)(395)
Interest and debt expense(334)(355)(360)(301)(11,455)(12,281)
Income from continuing operations before equity method investments, income taxes:72,15278,81471,62070,91780,15471,663
Other undisclosed loss from continuing operations before income taxes   (47,257)  
Income from continuing operations before income taxes:72,15278,81471,62023,66080,15471,663
Income tax expense(15,118)(26,922)(14,311)(20,762)(19,122)(17,286)
Net income:57,03451,89257,3092,89861,03254,377
Other undisclosed net income (loss) attributable to parent(10,338)(9,681)(9,843)51,826  
Net income available to common stockholders, diluted:46,69642,21147,46654,72461,03254,377

Comprehensive Income ($ in thousands)
Annual | Quarterly

3/31/2026
Q4
12/31/2025
Q3
9/30/2025
Q2
6/30/2025
Q1
3/31/2025
Q4
12/31/2024
Q3
9/30/2024
Q2
Net income:57,03451,89257,3092,89861,03254,377
Comprehensive income:57,03451,89257,3092,89861,03254,377
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(8,972)(9,026)(4,439)45,627(13,628)4,799
Comprehensive income, net of tax, attributable to parent:48,06242,86652,87048,52547,40459,176

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: